ZA774376B - Pharmaceutical compositions having an action on the central nervous system - Google Patents
Pharmaceutical compositions having an action on the central nervous systemInfo
- Publication number
- ZA774376B ZA774376B ZA00774376A ZA774376A ZA774376B ZA 774376 B ZA774376 B ZA 774376B ZA 00774376 A ZA00774376 A ZA 00774376A ZA 774376 A ZA774376 A ZA 774376A ZA 774376 B ZA774376 B ZA 774376B
- Authority
- ZA
- South Africa
- Prior art keywords
- action
- pharmaceutical compositions
- nervous system
- central nervous
- central
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7622045A FR2358881A1 (en) | 1976-07-20 | 1976-07-20 | Neuroleptic compsn. contg. a gabamimetic potentiator - which is a benzylidene-amino-alkanoic acid deriv., for treating e.g. schizophrenia |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA774376B true ZA774376B (en) | 1978-06-28 |
Family
ID=9175888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA00774376A ZA774376B (en) | 1976-07-20 | 1977-07-20 | Pharmaceutical compositions having an action on the central nervous system |
Country Status (3)
Country | Link |
---|---|
BE (1) | BE856937A (en) |
FR (1) | FR2358881A1 (en) |
ZA (1) | ZA774376B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5231099A (en) * | 1991-04-15 | 1993-07-27 | Du Pont Merck Pharmaceutical Company | Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs |
-
1976
- 1976-07-20 FR FR7622045A patent/FR2358881A1/en active Granted
-
1977
- 1977-07-19 BE BE179459A patent/BE856937A/en not_active IP Right Cessation
- 1977-07-20 ZA ZA00774376A patent/ZA774376B/en unknown
Also Published As
Publication number | Publication date |
---|---|
FR2358881A1 (en) | 1978-02-17 |
BE856937A (en) | 1978-01-19 |
FR2358881B1 (en) | 1980-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS52125619A (en) | Pharmaceutical vehicle | |
NZ181619A (en) | 1-aminoalkoxy-4-substituted-1 2, 3, 4-tetrahydroiso-quinolines | |
GB2003467A (en) | 2,4-benzodiazepines | |
ZA777711B (en) | Hydrogenation | |
NZ186147A (en) | Sterolin pharmaceutical compositions | |
NZ184539A (en) | 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine pharmaceutical compositions | |
GB1520958A (en) | 11-deoxy-16-aryl - 17,18,19,20 - tetranorprostaglandins | |
IL48624A0 (en) | 2,3-dihydroergolines | |
PH14168A (en) | 2,4-pyrrolidinediones | |
AU1214076A (en) | 2,3-dihalogen-alkanoyl-ureas | |
GB1557694A (en) | 2,9 dichlorquinacridone | |
GB1522923A (en) | 1,4 - benzodiazepines | |
AU2574877A (en) | Pharmaceutical compositions | |
GB1547206A (en) | Pharmaceutical compositions | |
ZA772612B (en) | Pharmaceutical compositions | |
NZ182127A (en) | 6 ,17 -dihydroxy-1 -loweralkoxycarbonyl-3-oxo-17 -pregn-4-ene-21-carboxylic acid -lactones | |
GB1483330A (en) | 2,5-dimethoxy-4-chloroaniline | |
GB1554021A (en) | 4,5-didehydroprostaglandins | |
ZA774376B (en) | Pharmaceutical compositions having an action on the central nervous system | |
PH13909A (en) | 17(-acetylenic-androstenes,the pharmaceutical composition | |
HK3984A (en) | Pharmaceutical compositions | |
ZA766301B (en) | Substituted 2,1,3-benzothiadiazine | |
GB1554925A (en) | 2,3-methyl-eneprostaglandins | |
GB1556567A (en) | Pharmaceutical compositions having an action on the central nervous system | |
ZA771408B (en) | Pharmaceutical compositions |